How experiences become data: the process of eliciting adverse event, medical history and concomitant medication reports in antimalarial and antiretroviral interaction trials

BACKGROUND: Accurately characterizing a drug’s safety profile is essential. Trial harm and tolerability assessments rely, in part, on participants’ reports of medical histories, adverse events (AEs), and concomitant medications. Optimal methods for questioning participants are unclear, but different...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Allen, Elizabeth N, Mushi, Adiel K, Massawe, Isolide S, Vestergaard, Lasse S, Lemnge, Martha, Staedke, Sarah G, Mehta, Ushma, Barnes, Karen I, Chandler, Clare IR
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3832682/
https://ncbi.nlm.nih.gov/pubmed/24229315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2288-13-140
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados